OTC Markets OTCPK - Delayed Quote USD
Evofem Biosciences, Inc. (EVFM)
0.0090
+0.0004
+(4.65%)
At close: May 2 at 9:47:34 AM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Saundra Pelletier | Interim Chair, President & CEO | 1.18M | -- | 1970 |
| Ms. Ivy Zhang CPA | CFO & Secretary | 695.26k | -- | 1979 |
| Ms. Ellen Thomas | Chief of Staff | -- | -- | -- |
| Ms. Amy Raskopf | Chief Business Development Officer | -- | -- | -- |
| Ms. Kathy Gallo-Doyle | Senior Vice President of Commercial Operations | -- | -- | -- |
Evofem Biosciences, Inc.
7770 Regents Rd
Suite 113-618
San Diego, CA 92122-1967
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 32
Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Corporate Governance
Evofem Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 13, 2025 at 12:30 PM UTC - May 19, 2025 at 12:30 PM UTC
Evofem Biosciences, Inc. Earnings Date
Recent Events
Related Tickers
WINT Windtree Therapeutics, Inc.
0.9955
-0.45%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0011
-84.29%
DRMA Dermata Therapeutics, Inc.
0.8699
+5.90%
ADTX Aditxt, Inc.
2.2300
+3.72%
AIBT Aibotics Inc.
0.0220
0.00%
FNCH Finch Therapeutics Group, Inc.
12.74
-0.08%
GDTC CytoMed Therapeutics Limited
2.3200
-2.93%
BDRX Biodexa Pharmaceuticals Plc
1.4000
-3.45%
SCNI Scinai Immunotherapeutics Ltd.
2.7800
-3.81%
QNRX Quoin Pharmaceuticals, Ltd.
6.10
-7.15%